# Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants

> **NCT01853111** · PHASE1 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 1 (actual)

## Conditions studied

- Vascularized Composite Allotransplantation

## Interventions

- **BIOLOGICAL:** Interleukin-2

## Key facts

- **NCT ID:** NCT01853111
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-01
- **Primary completion:** 2019-12-20
- **Final completion:** 2020-03-10
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2021-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01853111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01853111, "Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01853111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*